Carole Bernhardt

发表

Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

P. Giral, E. Bruckert, T. Poynard, 2009, Hepatology.

A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C.

G. le Naour, T. Poynard, V. Ratziu, 2010, Human pathology.

A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France.

C. Renou, G. Perlemuter, V. Ratziu, 2012, Journal of hepatology.

56 LONG-TERM EFFICACY OF ROSIGLITAZONE IN NONALCOHOLIC STEATOHEPATITIS (NASH): RESULTS OF THE EXTENSION PHASE OF THE FLIRT-2 TRIAL

T. Poynard, V. Ratziu, J. Moussalli, 2009, Journal of Hepatology.

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.

Philippe Giral, André Grimaldi, P. Giral, 2008, Gastroenterology.

Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

P. Giral, E. Bruckert, T. Poynard, 2009, Hepatology.

A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France.

C. Renou, G. Perlemuter, V. Ratziu, 2012, Journal of hepatology.

Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit

S. Travis, P. Giral, E. Bruckert, 2010, Gut.

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.

P. Giral, E. Bruckert, S. Jacqueminet, 2008, Gastroenterology.